QT-interval variability and autonomic control in hypertensive subjects with left ventricular hypertrophy.

Left ventricular hypertrophy is a risk factor for sudden death. Malignant ventricular arrhythmias originate from altered cardiac repolarization. Ample data have described spatial abnormalities in cardiac repolarization [QT interval (QT) dispersion] in subjects with hypertension; more data are needed on temporal changes. This study was designed to assess the QT variability index (QTVI), the slope between QT and the RR interval (QT-RR(slope)) and spectral QT variability in subjects with arterial hypertension. The results were compared with those from a population at high risk of sudden death, i.e. patients with hypertrophic cardiomyopathy (HCM) who had received an implantable cardioverter/defibrillator (ICD), and those from normotensive control subjects. A total of 44 hypertensive subjects, six patients with HCM and an ICD and 33 control subjects underwent simultaneous short-term recording (256 beats) of QT, RR and systolic blood pressure variability, in the supine position, during controlled breathing. QTVI and spectral components of QT variability in the hypertensive group were significantly higher than in normotensive control subjects (P<0.001), but significantly lower than in patients with HCM and an ICD (P<0.001). The severity of left ventricular hypertrophy correlated significantly with QTVI and the ratio of low-frequency (LF) to high-frequency (HF) power obtained from the RR variability spectra (RR(LF/HF), slope=0.24, P<0.05; QTVI, slope=4.06, P<0.0001; intercept, slope=2.40, P<0.05; chi(2)=38.8; P<0.0001). The QT--RR slope was significantly higher only in patients with HCM and an ICD (P<0.001). In conclusion, the increased QTVI and the correlation of this index with left ventricular hypertrophy indicates that hypertension increases temporal cardiac repolarization abnormalities. At the level of the cardiac sinus node, this alteration is associated with increased sympathetic and reduced vagal modulation. As already noted in patients with HCM, the increased QTVI could be a factor responsible for triggering malignant ventricular arrhythmias in subjects with hypertension.

[1]  G. Breithardt,et al.  Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. , 1996 .

[2]  G. Piccirillo,et al.  QT interval dispersion and autonomic modulation in subjects with anxiety. , 1999, The Journal of laboratory and clinical medicine.

[3]  V Marigliano,et al.  Influence of age, the autonomic nervous system and anxiety on QT-interval variability. , 2001, Clinical science.

[4]  G. Piccirillo,et al.  Autonomic modulation of heart rate and blood pressure in hypertensive subjects with symptoms of anxiety. , 1998, Clinical science.

[5]  W J McKenna,et al.  Assessment of Heart Rate Variability in Hypertrophic Cardiomyopathy Association With Clinical and Prognostic Features , 1993, Circulation.

[6]  P. Sleight,et al.  QT interval dynamics and heart rate variability preceding a case of cardiac arrest. , 1997, Heart.

[7]  H Calkins,et al.  Beat‐to‐Beat Repolarization Lability Identifies Patients at Risk for Sudden Cardiac Death , 1998, Journal of cardiovascular electrophysiology.

[8]  P. Vokonas,et al.  Symptoms of anxiety and risk of coronary heart disease. The Normative Aging Study. , 1994, Circulation.

[9]  H. Calkins,et al.  Beat-to-beat QT interval variability: novel evidence for repolarization lability in ischemic and nonischemic dilated cardiomyopathy. , 1997, Circulation.

[10]  G. Piccirillo,et al.  Influence of aging on cardiac baroreflex sensitivity determined non-invasively by power spectral analysis. , 2001, Clinical science.

[11]  G. Tomaselli,et al.  Electrophysiological remodeling in hypertrophy and heart failure. , 1999, Cardiovascular research.

[12]  H Calkins,et al.  Temporal repolarization lability in hypertrophic cardiomyopathy caused by beta-myosin heavy-chain gene mutations. , 2000, Circulation.

[13]  H V Huikuri,et al.  Dispersion of QT interval in patients with and without susceptibility to ventricular tachyarrhythmias after previous myocardial infarction. , 1995, Journal of the American College of Cardiology.

[14]  A. Porta,et al.  Spectral analysis of short term R-Tapex interval variability during sinus rhythm and fixed atrial rate. , 1996, European heart journal.

[15]  G. Piccirillo,et al.  Autonomic modulation and QT interval dispersion in hypertensive subjects with anxiety. , 1999, Hypertension.

[16]  S. Cerutti,et al.  Can power spectral analysis of heart rate variability identify a high risk subgroup of congestive heart failure patients with excessive sympathetic activation? A pilot study before and after heart transplantation. , 1994, British heart journal.

[17]  D. Levy,et al.  Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. , 1998, Journal of the American College of Cardiology.

[18]  P. Coumel,et al.  Changes in Repolarization Dynamicity and the Assessment of the Arrhythmic Risk , 1997, Pacing and clinical electrophysiology : PACE.

[19]  M Pagani,et al.  Absence of low-frequency variability of sympathetic nerve activity in severe heart failure. , 1997, Circulation.

[20]  Shimon Abboud,et al.  Real-Time PC-Based System for Dynamic Beat-to-Beat QT-RR Analysis , 1999, Comput. Biomed. Res..

[21]  M. N. Levy.  Role of Calcium in Arrhythmogenesis , 1989, Circulation.

[22]  F. Van de Werf,et al.  Enhanced Ca2 Release and Na/Ca Exchange Activity in Hypertrophied Canine Ventricular Myocytes: Potential Link Between Contractile Adaptation and Arrhythmogenesis , 2000, Circulation.

[23]  J. Laragh,et al.  Standardization of M-mode echocardiographic left ventricular anatomic measurements. , 1984, Journal of the American College of Cardiology.

[24]  E. Rimm,et al.  Prospective study of phobic anxiety and risk of coronary heart disease in men. , 1994, Circulation.

[25]  E. Williams.  Antiarrhythmic therapy: A pathophysiologic approach By Members of the Sicilian Gambit. (Pp 263; $65.) Armonk, NY: Futura, 1994. ISBN 0-87993-596-0 , 1995 .